Neuroprotection in brain and spinal cord trauma

Current Opinion in Anaesthesiology

Volumn 18, Issue 2, 2005, Pages 181-187

  Fu, Eugene S ^a   Tummala, Ramachandra P ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Neuroprotection; Neurotrauma; Spinal cord injury; Traumatic brain injury

Indexed keywords

ERYTHROPOIETIN; ESTROGEN; MAGNESIUM; METHYLPREDNISOLONE; MINOCYCLINE; PROGESTERONE;

BRAIN INJURY; BRAIN OXYGEN CONSUMPTION; BRAIN PERFUSION; CONSCIOUSNESS DISORDER; DRUG MECHANISM; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPOTHERMIA; INTRACRANIAL PRESSURE; MUSCLE WEAKNESS; NEUROPROTECTION; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SEPSIS; SPINAL CORD INJURY; THROMBOSIS;

EID: 17144422879     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aco.0000162838.56344.88     Document Type: Review

References (59)

1. Bruns J, Hauser WA. The epidemiology of traumatic brain injury: a review. Epilepsia 2003; 44(Suppl 10):2-10. This is a recent review of the morbidity and mortality associated with TBI.
2. Sekhorn LHS, Fehlings MG. Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine 2001; 26(Suppl 24):2-12.
3. Bedell E, Prough DS. Anesthetic management of traumatic brain injury. Anesthesiol Clin North Am 2002; 20:417-439.
4. Robertson CS. Management of cerebral perfusion pressure after traumatic brain injury. Anesthesiology 2001; 95:1513-1517.
5. Menon DK, Procrustes, the traumatic peunumbra, and perfusion pressure targets in closed head injury. Anesthesiology 2003; 98:805-807.
6. Nordstrom CH, Reinstrup P, Xu W, et al. Assessment of the lower limit for cerebral perfusion pressure in severe head injuries by bedside monitoring of regional energy metabolism. Anesthesiology 2003; 98:809-814. This prospective clinical study utilizes intracerebral microdialysis to measure lactate concentrations in relation to CPP.
7. Gunnarsson T, Fehlings MG. Acute neurosurgical management of traumatic brain injury and spinal cord injury. Curr Opin Neurol 2003; 16:717-723. This review highlights recent advances and controversies in the management of patients with brain and spinal cord trauma.
8. Farin A, Marshall LF. Lessons from epidemiologic studies in clinical trails of traumatic brain injury. Acta Neurochir Suppl 2004; 89:101-107. This article summarizes lessons learned from experiences with clinical trials in TBI.
9. Maas AIR, Marmarou A, Murray GD, Steyerberg EW. Clinical trial in traumatic brain injury current problems and future solutions. Acta Neurochir Suppl 2004; 89:113-118. This article reviews the complexities involved in the design of phase III trials in the clinical treatment of TBI.
10. Vink R, Van Den Huevel C. Recent advances in the development of multi-factorial therapies for the treatment of traumatic brain injury. Expert Opin Investig Drugs 2004; 13:1263-1274. This article reviews the development of neuropharmacologic approaches and strategies for the clinical treatment of TBI.
11. Stevens RD, Bhardwaj A, Kirsch JR, Mirski MA. Critical care and perioperative management in traumatic spinal cord injury. J Neurosurg Anesthesiol 2003; 15:215-229. This article is a review of neuroprotection and the perioperative management of patients with spinal cord trauma.
12. Hurlbert RJ. Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J Neurosurg Spine 2000; 93:1-7.
13. Short D. Is the role of steroids in acute spinal cord injury now resolved? Curr Opin Neurol 2001; 14:759-763.
14. American Association of the Neurologic Surgeons and the Congress of Neurologic Surgeons. Guidelines of the American Association of the Neurologic Surgeons and the Congress of Neurologic Surgeons. Pharmacological therapy after acute spinal cord injury. Neurosurgery 2002; 50(Suppl): 63-72.
15. Baughman VL. Brain protection during neurosurgery. Anesthesiol Clin North Am 2002; 20:315-327.
16. Fritz HG, Bauer R. Secondary injuries in brain trauma: effects of hypothermia. J Neurosurg Anesthesiol 2004; 16:43-52. This article reviews experimental and clinical investigations into the effect of hypothermia in TBI.
17. Wagner AK, Bayir H, Ren D, et al. Relationships between cerebrospinal fluid markers of excitotoxicity, ischemia, and oxidative damage after severe TBI: the impact of gender, age, and hypothermia. J Neurotrauma 2004; 21:125-136. This article reviews the relationship of hypothermia and gender in patients with TBI.
18. Jiang J, Yu M, Zhu C. Effect of long-term mild hypothermia therapy in patients with severe traumatic brain injury: 1-year follow-up review of 87 cases. J Neurosurg 2000; 93:546-549.
19. Clifton GL, Miller ER, Choi SC, et al. Lack of effect of hypothermia after acute brain injury. N Engl J Med 2001; 344:556-563.
20. Suehiro E, Ueda Y, Wei EP, et al. Posttraumatic hypothermia followed by slow rewarming protects the cerebral microcirculation. J Neurotrauma 2003; 20:381-390.
21. McIntyre LA, Fergusson DA, Hebert PC, et al. Prolonged therapeutic hypothermia after traumatic brain injury in adults a systematic review JAMA 2003; 289:2992-2999. This article is a meta-analysis detailing 12 clinical trials on the effect of therapeutic hypothermia in adults with TBI.
22. Yu CG, Jiminez O, Marcillo AE, et al. Beneficial effects of modest systemic hypothermia on locomotor function and histopathological damage following confusion-induced spinal cord injury in rats. J Neurosurg Spine 2000; 93: 85-93.
23. Shibuya S, Miyamoto O, Janjua NA, et al. Post-traumatic moderate systemic hypothermia reduces TUNEL positive cells following spinal cord injury in rat. Spinal Cord 2004; 42:29-34.
24. Inamasu J, Nakamura Y, Ichikizaki K. Induced hypothermia in experimental traumatic spinal cord injury: an update. J Neural Sci 2003; 209:55-60. This article reviews the use of induced hypothermia in experimental SCI and examines the feasibility of hypothermia for clinical use.
25. Wagner AK, Willard LA, Kline AE, et al. Evaluation of estrous cycle stage and gender on behavioral outcome after experimental traumatic brain injury. Brain Res 2004; 998:113-121. This laboratory investigation evaluated the effect of gender on motor tasks and spatial memory in rats undergoing cortical compaction injury.
26. Goodman Y, Bruce AJ, Cheng B, Mattson MP. Estrogens attenuate and corticosterone exacerbates excitotoxic oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J Neurochem 1996; 66:1836-1844.
27. Suzuki T, Bramlett HM, Dietrich WD. The importance of gender on the beneficial effects of posttraumatic hypothermia. Exp Neurol 2003; 184: 1017-1026. This article reports an experimental investigation that evaluated the role of gender on the therapeutic effects of hypothermia following TBI in rats.
28. Behl C. Oestrogen as a neuroprotective hormone. Nat Rev Neurosci 2002; 3:433-442.
29. Nilsen J, Chen S, Brinton RD. Dual action of estrogen on glutamate-induced calcium signaling: mechanisms requiring interaction between estrogen receptors and src/mitogen activated protein kinase pathway. Brain Res 2002; 930:216-234.
30. Zhao L, Wu TW, Brinton RD. Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons. Brain Res 2004; 1010:22-34. This article evaluates the role of estrogen receptors in promoting neuroprotection in hippocampal neurons.
31. Mize AL, Shapiro RA, Dorsa DM. Estrogen receptor-mediated neuroprotection from oxidative stress requires activation of the mitogen-activated protein kinase pathway. Endocrinology 2003; 144:306-312.
32. Limmroth V, Lee WS, Moskowitz MA. GABA-receptor-mediated effects of progesterone, its ring-A-reduced metabolites and synthetic neuroactive steroids on neurogenic oedema in the rat meninges. Br J Pharmacol 1996; 117:99-104.
33. Drew PD, Chavis J. Female sex steroids: effects upon microglial cell activation. J Neuroimmunol 2000; 111:77-85.
34. He J, Evans CO, Hoffman SW, et al. Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury. Exp Neurol 2004; 189:404-412. This article is an experimental investigation demonstrating the effects of progesterone and its metabolites in reducing cerebral edema and inflammatory cytokine production after TBI in rats.
35. He J, Hoffman SW, Stein DG. Allopregnanolone, a progesterone metabolite, enhances behavioral recovery and decreases neuronal loss after traumatic brain injury. Restor Neurol Neurosci 2004; 2002:19-31. This article reports an experimental investigation demonstrating the effects of the progesterone metabolite alloprenanolone on cognitive and behavioral recovery after TBI in rats.
36. Gonzalez SL, Labombarda F, Gonzalez Deniselle MC, et al. Progesterone up-regulates neuronal brain-derived neurotrophic factor expression in the injured spinal cord. Neuroscience 2004; 125:605-614.
37. Farace E, Alves WM. Do women fare worse: a metaanalysis of gender differences in traumatic brain injury outcome. J Neurosurg 2000; 93:539-545.
38. Bayir H, Marion DW, Puccio AM, et al. Marked gender effect of lipid peroxidation after severe traumatic brain injury in adult patients. J Neurotrauma 2004; 21:1-8. This article assesses the effect of gender on lipid peroxidation in adult patients after TBI.
39. Sanchez Mejia RO, Ona VO, Li M, Friedlander RM. Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neurosurgery 2001; 48:1393-1401.
40. Wells JEA, Hurlbert RJ, Fehlings MG, Yong VW. Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain 2003; 126:1628-1637. This article is an experimental investigation demonstrating that minocycline improves histopathology and functional recovery after SCI in mice.
41. Liu XZ, Xu XM, Hu R, et al. Neuronal and glial apoptosis after traumatic spinal cord injury. J Neurosci 1997; 17:5395-5406.
42. Li M, Ona VO, Chen M, et al. Functional role and therapeutic implications of neuronal caspase-1 and -3 in a mouse model of traumatic spinal cord injury. Neuroscience 2000; 99:333-342.
43. Zhu S, Stavrovskaya IG, Drozda M, et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 2002; 417:74-78.
44. Wang X, Zhu S, Drozda M, et al. Minocycline inhibits caspase-independent and dependent mitochondrial cell death pathways in models of Huntington's disease. Proc Natl Acad Sci USA 2003; 100:10483-10487.
45. Teng YD, Choi H, Onario RC, et al. Minocycline inhibits confusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. Proc Natl Acad Sci USA 2004; 101: 3071-3076. This article evaluates the role played by minocycline in inhibiting mitochondrial cytochrome c release and functional recovery after SCI in rats.
46. Sasaki R. Pleiotropic functions of erythropoietin. Intern Med 2003; 42:142-149.
47. Leist M, Ghezzi P, Grasso G, et al. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 2004; 305:239-242. This article provides a detailed analysis of the neuroprotective functions of derivatives of erythropoietin.
48. Kaptanoglu E, Solaroglu I, Okutan O, et al. Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: effect on lipid peroxidation and early ultrastructural findings. Neurosurg Rev 2004; 27:113-120. This is an experimental investigation that compared the effects of erythropoietin and methylprednisolone in acute SCI in rats.
49. Ehrenreich H, Hasselblatt M, Dembowski C, et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 2002; 8:495-505.
50. Weissner C, Allegrini PR, Ekatodramis D, et al. Increase cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin. J Cereb Blood Flow Metab 2001; 21:857-864.
51. Grasso G, Sfacteria A, Cerami A, Brines M. Erythropoietin as a tissue-protective cytokine in brain injury: what do we know and where do we go? Neuroscientist 2004; 10:93-98.
52. Erbayraktar S, Grasso G, Sfacteria, et al. Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc Natl Acad Sci USA 2003; 11:6741-6746. This is an experimental investigation that evaluated the effects of nonerythropoietic derivatives in various models of neural injury.
53. Pravdenkova SV, Baknakian AG, James SJ, Anderson BJ. DNA fragmentation and nuclear endonuclease activity in rat brain after severe closed head injury. Brain Res 1996; 729:151-155.
54. Lee JS, Han YM, Yoo DS, et al. A molecular basis for the efficacy of magnesium treatment following traumatic brain injury in rats. J Neurotrauma 2004; 21:549-561. This is an experimental investigation that evaluated the role played by magnesium on the expression of apoptotic proteins after TBI in rats.
55. Vink R, Cernak I. Regulation of intracellular free magnesium in central nervous system injury. Front Biosci 2000; 5:D656-D665.
56. Vink R, Donkin JJ, Cruz MI, et al. A substance P antagonist increases brain intracellular free magnesium concentration after diffuse traumatic brain injury in rats. J Am Coll Nutr 2004; 23:538S-540S.
57. Kramer JH, Mak IT, Phillips TM, Weglicki WB. Dietary magensim intake influence circulating pro-inflammatory neuropeptide levels and loss of myocardial tolerance to postischemic stress. Exp Biol Med 2003; 228:665-673.
58. Suzer T, Coskun E, Islekel H, Tahta K. Neuroprotective effect of magnesium on lipid peroxidation and axonal function after experimental spinal cord injury. Spinal Cord 1999; 37:480-484.
59. Kaptanoglu E, Beskonakli E, Okutan O, et al. Effect of magnesium sulphate in experimental spinal cord injury: evaluation with ultrastructural findings and early clinical results. J Clin Neurosci 2003; 10:329-334. This is an experimental investigation that evaluated the effects of magnesium on spinal cord ultrastructure and functional neurological scoring after contusion injury.